Login to Your Account

TCM Compound for IBS, Crohn’s Moves into Phase III Testing

By Shannon Ellis
Staff Writer

Wednesday, September 18, 2013
SHANGHAI – A joint venture between a Chinese and a Swiss company has launched Phase III trials for a botanical drug to treat inflammatory bowel disease.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription